Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
B5940 TP-0903Target: AXLSummary: AXL receptor tyrosine kinase inhibitor, anti-cancer agent -
A1655 GW25801 CitationTarget: CSF-1RSummary: CFMS kinase/CSF-1R inhibitor,selective and ATP-competitive -
A8192 Staurosporine22 CitationSummary: serine/threonine protein kinases inhibitor -
A3794 SB1317Summary: CDK,JAK and FLT inhibitor -
A8232 Nilotinib(AMN-107)9 CitationTarget: Bcr-AblSummary: BCR-ABL inhibitor -
A3843 SU 54024 CitationTarget: VEGFR|PDGFR|FGFRSummary: VEGFR2/FGFR/PDGFR/EGFR inhibitor -
A4475 TLQP 21Summary: VGF-derived peptide -
A4513 Lestaurtinib1 CitationSummary: JAK2/FLT3/TrkA inhibitor -
A3967 Lapatinib DitosylateTarget: EGFR|ErbB-2Summary: EGFR/HER2 inhibitor,potent and selective -
A3969 Vatalanib1 CitationTarget: VEGFRSummary: VEGFR-1/-2 inhibitor,cell-permeable
